Expression of the type 1 pneumococcal pilus is bistable and negatively regulated by the structural component RrgA

Infection and Immunity

Volumn 79, Issue 8, 2011, Pages 2974-2983

  Basset, Alan ^a   Turner, Keith H ^a   Boush, Elizabeth ^a   Sayeed, Sabina ^a   Dove, Simon L ^a   Malley, Richard ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; RRGA PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BACTERIUM PILUS; CELL POPULATION; GENE EXPRESSION; GENE REPRESSION; GENETIC STABILITY; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; TRANSCRIPTION INITIATION; TYPE 1 PNEUMOCOCCAL PILUS;

BACTERIAL PROTEINS; FIMBRIAE, BACTERIAL; GENE DELETION; GENE EXPRESSION REGULATION, BACTERIAL; GENOMIC ISLANDS; HUMANS; MULTIGENE FAMILY; PHENOTYPE; PROTEIN BINDING; PROTEIN INTERACTION MAPPING; REPRESSOR PROTEINS; STREPTOCOCCUS PNEUMONIAE; TRANS-ACTIVATORS;

EID: 79961105901     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.05117-11     Document Type: Article

References (39)

1. Avery, O. T., C. M. Macleod, and M. McCarty. 1944. Studies on the chemical nature of the substance inducing transformation of pneumococcal types, induction of transformation by a desoxyribonucleic acid fraction isolated from pneumococcus type III. J. Exp. Med. 79, 137-158.
2. Bagnoli, F., et al. 2008. A second pilus type in Streptococcus pneumoniae is prevalent in emerging serotypes and mediates adhesion to host cells. J. Bacteriol. 190, 5480-5492.
3. Balachandran, P., A. Brooks-Walter, A. Virolainen-Julkunen, S. K. Hollingshead, and D. E. Briles. 2002. Role of pneumococcal surface protein C in nasopharyngeal carriage and pneumonia and its ability to elicit protection against carriage of Streptococcus pneumoniae. Infect. Immun. 70, 2526-2534.
4. Barocchi, M. A., et al. 2006. A pneumococcal pilus influences virulence and host inflammatory responses. Proc. Natl. Acad. Sci. U. S. A. 103, 2857-2862.
5. Basset, A., et al. 2007. Association of the pneumococcal pilus with certain capsular serotypes but not with increased virulence. J. Clin. Microbiol. 45, 1684-1689.
6. Black, S., et al. 2000. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Pediatr. Infect. Dis. J. 19, 187-195.
7. Black, S. B., et al. 2001. Postlicensure evaluation of the effectiveness of seven valent pneumococcal conjugate vaccine. Pediatr. Infect. Dis. J. 20, 1105-1107.
8. Briles, D. E., et al. 2000. The potential to use PspA and other pneumococcal proteins to elicit protection against pneumococcal infection. Vaccine 18, 1707-1711.
9. Castang, S., H. R. McManus, K. H. Turner, and S. L. Dove. 2008. H-NS family members function coordinately in an opportunistic pathogen. Proc. Natl. Acad. Sci. U. S. A. 105, 18947-18952.
10. Crotty Alexander, L. E., et al. 2010. M1T1 group A streptococcal pili promote epithelial colonization but diminish systemic virulence through neutrophil extracellular entrapment. J. Mol. Med. 88, 371-381.
11. Falker, S., et al. 2008. Sortase-mediated assembly and surface topology of adhesive pneumococcal pili. Mol. Microbiol. 70, 595-607.
12. Gentile, M. A., et al. 2011. Structural and functional characterization of the Streptococcus pneumoniae RrgB pilus backbone D1 domain. J. Biol. Chem. 286, 14588-14597.
13. Gianfaldoni, C., et al. 2007. Streptococcus pneumoniae pilus subunits protect mice against lethal challenge. Infect. Immun. 75, 1059-1062.
14. Hanage, W. P. 2008. Serotype-specific problems associated with pneumococcal conjugate vaccination. Future Microbiol. 3, 23-30.
15. Hava, D. L., C. J. Hemsley, and A. Camilli. 2003. Transcriptional regulation in the Streptococcus pneumoniae rlrA pathogenicity islet by RlrA. J. Bacteriol. 185, 413-421.
16. Hilleringmann, M., et al. 2008. Pneumococcal pili are composed of protofilaments exposing adhesive clusters of Rrg A. PLoS Pathog. 4, e1000026.
17. Hilleringmann, M., et al. 2009. Molecular architecture of Streptococcus pneumoniae TIGR4 pili. EMBO J. 28, 3921-3930.
18. Horton, R. M., Z. L. Cai, S. N. Ho, and L. R. Pease. 1990. Gene splicing by overlap extension, tailor-made genes using the polymerase chain reaction. Biotechniques 8, 528-535.
19. Lacks, S. 1966. Integration efficiency and genetic recombination in pneumococcal transformation. Genetics 53, 207-235.
20. LeMieux, J., D. L. Hava, A. Basset, and A. Camilli. 2006. RrgA and RrgB are components of a multisubunit pilus encoded by the Streptococcus pneumoniae rlrA pathogenicity islet. Infect. Immun. 74, 2453-2456.
21. Lewis, K. 2007. Persister cells, dormancy and infectious disease. Nat. Rev. 5, 48-56.
22. Lipsitch, M. 2001. Interpreting results from trials of pneumococcal conjugate vaccines, a statistical test for detecting vaccine-induced increases in carriage of nonvaccine serotypes. Am. J. Epidemiol. 154, 85-92.
23. Livak, K. J., and T. D. Schmittgen. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(+Delta Delta C(T)) method. Methods 25, 402-408.
24. Maisey, H. C., M. Hensler, V. Nizet, and K. S. Doran. 2007. Group B streptococcal pilus proteins contribute to adherence to and invasion of brain microvascular endothelial cells. J. Bacteriol. 189, 1464-1467.
25. Maisey, H. C., et al. 2008. A group B streptococcal pilus protein promotes phagocyte resistance and systemic virulence. FASEB J. 22, 1715-1724.
26. Malley, R., et al. 2003. Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection. Proc. Natl. Acad. Sci. U. S. A. 100, 1966-1971.
27. Moschioni, M., et al. 2010. The two variants of the Streptococcus pneumoniae pilus 1 RrgA adhesin retain the same function and elicit crossprotection in vivo. Infect. Immun. 78, 5033-5042.
28. Munoz-Elias, E. J., J. Marcano, and A. Camilli. 2008. Isolation of Streptococcus pneumoniae biofilm mutants and their characterization during nasopharyngeal colonization. Infect. Immun. 76, 5049-5061.
29. Muzzi, A., M. Moschioni, A. Covacci, R. Rappuoli, and C. Donati. 2008. Pilus operon evolution in Streptococcus pneumoniae is driven by positive selection and recombination. PLoS One 3, e3660.
30. Nelson, A. L., et al. 2007. RrgA is a pilus-associated adhesin in Streptococcus pneumoniae. Mol. Microbiol. 66, 329-340.
31. O'Brien, K. L., et al. 2009. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years, global estimates. Lancet 374, 893-902.
32. Ogunniyi, A. D., R. L. Folland, D. E. Briles, S. K. Hollingshead, and J. C. Paton. 2000. Immunization of mice with combinations of pneumococcal virulence proteins elicits enhanced protection against challenge with Streptococcus pneumoniae. Infect. Immun. 68, 3028-3033.
33. Regev-Yochay, G., et al. 2010. Re-emergence of the type 1 pilus among Streptococcus pneumoniae isolates in Massachusetts, USA. Vaccine 28, 4842-4846.
34. Spraggon, G., et al. 2010. Supramolecular organization of the repetitive backbone unit of the Streptococcus pneumoniae pilus. PLoS One 5, e10919.
35. Srivastava, A., et al. 2005. The apoptotic response to pneumolysin is Toll-like receptor 4 dependent and protects against pneumococcal disease. Infect. Immun. 73, 6479-6487.
36. Sung, C. K., H. Li, J. P. Claverys, and D. A. Morrison. 2001. An rpsL cassette, Janus, for gene replacement through negative selection in Streptococcus pneumoniae. Appl. Environ. Microbiol. 67, 5190-5196.
37. Turner, K. H., I. Vallet-Gely, and S. L. Dove. 2009. Epigenetic control of virulence gene expression in Pseudomonas aeruginosa by a LysR-type transcription regulator. PLoS Genet. 5, e1000779.
38. Vallet-Gely, I., J. S. Sharp, and S. L. Dove. 2007. Local and global regulators linking anaerobiosis to cupA fimbrial gene expression in Pseudomonas aeruginosa. J. Bacteriol. 189, 8667-8676.
39. van der Woude, M. W., and A. J. Baumler. 2004. Phase and antigenic variation in bacteria. Clin. Microbiol. Rev. 17, 581-611.